CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | Kompella Uday Director | Sale | −25,000 | $16.01 | $400K | 154,416 |
| 2021-11-02 | Potti Manish Director | Sale | −63,429 | $15.07 | $956K | 27,695 |
| 2021-11-02 | Castillo Kirsten Director | Sale | −15,000 | $15.00 | $225K | 50,000 |
| 2021-11-02 | Zhang Junge Director | Sale | −149,700 | $15.75 | $2.4M | 881,731 |
| 2021-11-01 | Kompella Uday Director | Sale | −25,000 | $14.05 | $351K | 179,416 |
| 2021-11-01 | Musunuri Shankar Chief Executive Officer | Option exercise | +115,367 | $0.51 | $59K | 521,367 |
| 2021-11-01 | Musunuri Shankar Chief Executive Officer | Sale | −115,367 | $14.15 | $1.6M | 406,000 |
| 2021-11-01 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −115,367 | 622,352 | ||
| 2021-10-26 | Subramanian Sanjay Chief Financial Officer | Sale | −10,000 | $11.07 | $111K | 35,591 |
| 2021-10-26 | Kompella Uday Director | Sale | −25,000 | $12.05 | $301K | 204,416 |
| 2021-10-25 | Kompella Uday Director | Sale | −46,371 | $9.08 | $421K | 229,416 |
| 2021-10-21 | Kompella Uday Director | Sale | −1,898 | $9.01 | $17K | 275,787 |
| 2021-10-20 | Kompella Uday Director | Sale | −1,731 | $9.02 | $16K | 277,685 |
| 2021-10-18 | Kompella Uday Director | Sale | −200,000 | $8.41 | $1.7M | 279,416 |
| 2021-10-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2021-10-18 | Kumar Ramesh Director | Sale | −7,500 | $8.13 | $61K | 0 |
| 2021-10-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −7,500 | 31,500 | ||
| 2021-10-15 | Musunuri Shankar Chief Executive Officer | Option exercise | +125,000 | $0.33 | $41K | 531,000 |
| 2021-10-15 | Musunuri Shankar Chief Executive Officer | Sale | −125,000 | $9.80 | $1.2M | 406,000 |
| 2021-10-15 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −125,000 | 1,076,587 |
Page 8 of 27 · 525 trades